Compounds > phenylalanine

phenylalanine and Precancerous Conditions

phenylalanine has been researched along with Precancerous Conditions in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19904 (33.33)18.7374
1990's0 (0.00)18.2507
2000's4 (33.33)29.6817
2010's4 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altieri, S; Aromando, RF; Bortolussi, S; Garabalino, MA; Heber, EM; Itoiz, ME; Molinari, AJ; Monti Hughes, A; Portu, AM; Pozzi, EC; Saint Martin, G; Schwint, AE; Thorp, SI; Trivillin, VA1
Aromando, RF; Blaumann, H; Calzetta, O; Heber, EM; Itoiz, ME; Longhino, J; Monti Hughes, A; Nievas, SI; Nigg, DW; Pozzi, E; Schwint, AE; Trivillin, VA1
Aromando, RF; Heber, EM; Itoiz, ME; Pozzi, E; Schwint, AE; Trivillin, VA1
Chang, PY; Hsia, KT; Huang, SH; Lin, MW; Liu, CJ1
Aromando, RF; Garabalino, MA; Heber, EM; Itoiz, ME; Miller, M; Molinari, AJ; Monti Hughes, A; Nigg, DW; Pozzi, EC; Schwint, AE; Thorp, S; Trivillin, VA1
Batistoni, D; Heber, E; Itoiz, ME; Kreimann, EL; Nigg, D; Rebagliati, RJ; Schwint, AE; Trivillin, VA1
Batistoni, D; Gonzalez, BN; Heber, EM; Itoiz, ME; Kreimann, EL; Nigg, DW; Rebagliati, RJ; Schwint, AE; Trivillin, VA1
Hayashi, S; Izumi, S; Kurihara, S; Nozawa, S; Ohta, H; Tsutsui, F; Watanabe, K1
Blaumann, H; Calzetta, O; Itoiz, ME; Kreimann, EL; Longhino, J; Schwint, AE1
Bhargava, PM; Bornecque, CA; Szafarz, D; Zajdela, F1
Briggs, GM; DeOme, KB; Hui, YH1
Goldman, M; Griffin, AC1

Other Studies

12 other study(ies) available for phenylalanine and Precancerous Conditions

ArticleYear
Assessing advantages of sequential boron neutron capture therapy (BNCT) in an oral cancer model with normalized blood vessels.
    Acta oncologica (Stockholm, Sweden), 2015, Volume: 54, Issue:1

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cricetinae; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Phenylalanine; Precancerous Conditions; Thalidomide

2015
Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2009, Volume: 67, Issue:7-8 Suppl

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Cricetinae; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents; Sulfhydryl Compounds; Tissue Distribution

2009
Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch.
    Oral oncology, 2010, Volume: 46, Issue:5

    Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Count; Cell Line, Tumor; Cell Proliferation; Cheek; Cricetinae; Mast Cells; Mouth Neoplasms; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents

2010
O6-methylguanine-DNA methyltransferase gene coding region polymorphisms and oral cancer risk.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2010, Volume: 39, Issue:8

    Topics: Age Factors; Carcinoma, Squamous Cell; Case-Control Studies; Codon; Cytosine; Disease-Free Survival; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; Haplotypes; Humans; Leucine; Linkage Disequilibrium; Male; Middle Aged; Mouth Neoplasms; O(6)-Methylguanine-DNA Methyltransferase; Phenylalanine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Precancerous Conditions; Retrospective Studies; Risk Factors; Sequence Analysis, DNA; Survival Rate; Taiwan; Thymine

2010
Boron Neutron Capture Therapy (BNCT) in an oral precancer model: therapeutic benefits and potential toxicity of a double application of BNCT with a six-week interval.
    Oral oncology, 2011, Volume: 47, Issue:11

    Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Disease Models, Animal; DNA; Mouth Neoplasms; Mucositis; Phenylalanine; Precancerous Conditions; Radiation Injuries, Experimental; Treatment Outcome

2011
Biodistribution of GB-10 (Na(2)(10)B10H10 compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch.
    Archives of oral biology, 2004, Volume: 49, Issue:4

    Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Drug Combinations; Drug Interactions; Models, Animal; Mouth Neoplasms; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents

2004
Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model.
    Archives of oral biology, 2006, Volume: 51, Issue:10

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Disease Models, Animal; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Phenylalanine; Precancerous Conditions

2006
Heat-stable alkaline phosphatase in uterine cancer, with special reference to its histochemical heat-stability and the L-phenylalanine inhibition test.
    The Histochemical journal, 1981, Volume: 13, Issue:6

    Topics: Alkaline Phosphatase; Cervix Uteri; Endometrium; Female; Histocytochemistry; Humans; Phenylalanine; Precancerous Conditions; Uterine Cervical Neoplasms; Uterine Neoplasms; Uterus

1981
Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model.
    Cancer research, 2001, Dec-15, Volume: 61, Issue:24

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cheek; Cricetinae; Disease Models, Animal; Mesocricetus; Mouth Neoplasms; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents

2001
A comparison of the ability of normal liver, a premalignant liver, a solid hepatoma and the Zajdela ascitic hepatoma, to take up amino acids in vitro.
    The Journal of membrane biology, 1976, Feb-17, Volume: 26, Issue:1

    Topics: Amino Acids; Animals; Arginine; In Vitro Techniques; Kinetics; Leucine; Liver; Liver Neoplasms; Lysine; Methionine; Phenylalanine; Precancerous Conditions; Valine

1976
Inhibition of pituitary-induced nodular hyperplasia in mammary glands of C3H mice fed a phenylalanine-deficient diet.
    Journal of the National Cancer Institute, 1971, Volume: 46, Issue:5

    Topics: Adrenal Glands; Animals; Body Weight; Deficiency Diseases; Female; Hyperplasia; Kidney; Liver; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Organ Size; Ovary; Phenylalanine; Pituitary Gland; Precancerous Conditions; Transplantation, Homologous

1971
Transfer RNA patterns in livers of rats fed diets containing 3'-methyl-4-dimethylaminoazobenzene.
    Cancer research, 1970, Volume: 30, Issue:6

    Topics: Amino Acids; Animals; Arginine; Carbon Isotopes; Cell Transformation, Neoplastic; Chemical and Drug Induced Liver Injury; Chromatography; Female; Histidine; Leucine; Liver Diseases; Lysine; Methionine; Methylation; p-Dimethylaminoazobenzene; Phenylalanine; Precancerous Conditions; Rats; RNA, Transfer; Serine; Threonine; Tritium; Tyrosine; Valine

1970